Status:

Red

Decision Date:

October 2023

Comments

RED:

• NICE TA913 - Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again